173 related articles for article (PubMed ID: 11782995)
1. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms.
Momose Y; Murata M; Kobayashi K; Tachikawa M; Nakabayashi Y; Kanazawa I; Toda T
Ann Neurol; 2002 Jan; 51(1):133-6. PubMed ID: 11782995
[TBL] [Abstract][Full Text] [Related]
2. Toward identification of susceptibility genes for sporadic Parkinson's disease.
Toda T; Momose Y; Murata M; Tamiya G; Yamamoto M; Hattori N; Inoko H
J Neurol; 2003 Oct; 250 Suppl 3():III40-3. PubMed ID: 14579123
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.
Maraganore DM; Farrer MJ; Hardy JA; Lincoln SJ; McDonnell SK; Rocca WA
Neurology; 1999 Nov; 53(8):1858-60. PubMed ID: 10563640
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.
Mellick GD; Silburn PA
Neurosci Lett; 2000 Oct; 293(2):127-30. PubMed ID: 11027850
[TBL] [Abstract][Full Text] [Related]
5. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population.
Satoh J; Kuroda Y
J Neurol Sci; 2001 Aug; 189(1-2):113-7. PubMed ID: 11535241
[TBL] [Abstract][Full Text] [Related]
6. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson's disease in a Greek population.
Karakasis C; Kalinderi K; Katsarou Z; Fidani L; Bostantjopoulou S
J Clin Neurosci; 2011 Dec; 18(12):1744-5. PubMed ID: 22001244
[TBL] [Abstract][Full Text] [Related]
7. No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease.
Levecque C; Destée A; Mouroux V; Becquet E; Defebvre L; Amouyel P; Chartier-Harlin MC
J Neural Transm (Vienna); 2001; 108(8-9):979-84. PubMed ID: 11716150
[TBL] [Abstract][Full Text] [Related]
8. ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset.
Wang J; Zhao CY; Si YM; Liu ZL; Chen B; Yu L
Mov Disord; 2002 Jul; 17(4):767-71. PubMed ID: 12210873
[TBL] [Abstract][Full Text] [Related]
9. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
Guerini FR; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
Eur J Neurol; 2009 Nov; 16(11):1240-5. PubMed ID: 19538209
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.
Lincoln S; Vaughan J; Wood N; Baker M; Adamson J; Gwinn-Hardy K; Lynch T; Hardy J; Farrer M
Neuroreport; 1999 Feb; 10(2):427-9. PubMed ID: 10203348
[TBL] [Abstract][Full Text] [Related]
11. Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson's disease in a Han-Chinese population.
Zhang ZJ; Burgunder JM; An XK; Wu Y; Chen WJ; Zhang JH; Wang YC; Xu YM; Gou YR; Yuan GG; Mao XY; Peng R
Neurosci Lett; 2008 Sep; 442(3):200-2. PubMed ID: 18638528
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson's disease.
Mariani S; Ventriglia M; Simonelli I; Bucossi S; Siotto M; R RS
Rejuvenation Res; 2015 Feb; 18(1):40-7. PubMed ID: 25431370
[TBL] [Abstract][Full Text] [Related]
13. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.
Nishikawa K; Li H; Kawamura R; Osaka H; Wang YL; Hara Y; Hirokawa T; Manago Y; Amano T; Noda M; Aoki S; Wada K
Biochem Biophys Res Commun; 2003 Apr; 304(1):176-83. PubMed ID: 12705903
[TBL] [Abstract][Full Text] [Related]
14. S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship.
Elbaz A; Levecque C; Clavel J; Vidal JS; Richard F; Corrèze JR; Delemotte B; Amouyel P; Alpérovitch A; Chartier-Harlin MC; Tzourio C
Mov Disord; 2003 Feb; 18(2):130-7. PubMed ID: 12539205
[TBL] [Abstract][Full Text] [Related]
15. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
Liu Y; Fallon L; Lashuel HA; Liu Z; Lansbury PT
Cell; 2002 Oct; 111(2):209-18. PubMed ID: 12408865
[TBL] [Abstract][Full Text] [Related]
16. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden.
Carmine Belin A; Westerlund M; Bergman O; Nissbrandt H; Lind C; Sydow O; Galter D
Parkinsonism Relat Disord; 2007 Jul; 13(5):295-8. PubMed ID: 17287139
[TBL] [Abstract][Full Text] [Related]
17. An Ile93Met substitution in the UCH-L1 gene is not a disease-causing mutation for idiopathic Parkinson's disease.
Shi Q; Tao E
Chin Med J (Engl); 2003 Feb; 116(2):312-3. PubMed ID: 12775255
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease.
Chen CM; Chen IC; Chang KH; Chen YC; Lyu RK; Liu YT; Hu FJ; Chao CY; Lee-Chen GJ; Wu YR
Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):458-62. PubMed ID: 17427185
[TBL] [Abstract][Full Text] [Related]
20. No association between brain-derived neurotrophic factor G196A polymorphism and clinical features of Parkinson's disease.
Svetel M; Pekmezovic T; Markovic V; Novaković I; Dobričić V; Djuric G; Stefanova E; Kostić V
Eur Neurol; 2013; 70(5-6):257-62. PubMed ID: 24051673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
